Diabetes and Ramadan

Module 7: Applying ADA/EASD recommendations to the management of type 2 diabetes during Ramadan

Please log in to access the chapters in this module.
CME Credits: 1.5
Module duration: 1.5 hours
Launch date: Spring 2022 (version 1)
Updated: -
Expiry date: March 2027
Audience: Diabetes and Metabolism Specialists (Basic), Endocrinologists (Basic), General Physicians (Subspeciality)

Hello. My name is Ehtasham Ahmad. I’m a Clinical Research Fellow in Diabetes at the University of Leicester, UK. Today, I will be talking about the management of type 2 diabetes during the month of Ramadan using the principles of ADA and EASD consensus recommendations. Fasting during the holy month of Ramadan is considered one of the five pillars of Islam. And although people with chronic conditions like diabetes are considered exempt from fasting, many still choose to fast. As their healthcare providers, it is our responsibility to respect their decision and help them fast safely during Ramadan. My talk will be divided into two parts. First, we’ll focus around the principles, using the principles of ADA and EASD consensus recommendations during Ramadan. And secondly, will focus around the use of novel agents during Ramadan.

This module looks at how we can best apply the ADA/EASD consensus guidelines for the management of hyperglycaemia in type 2 diabetes to people with type 2 diabetes during Ramadan, focusing firstly on the principles that should guide your practice in this area and, secondly, on the use of novel agents during Ramadan.

Ibrahim M, Davies MJ, Ahmad E, Annabi FA, Eckel RH, Ba-Essa EM, El Sayed NA, Hess Fischl A, Houeiss P, Iraqi H, Khochtali I, Khunti K, Masood SN, Mimouni-Zerguini S, Shera S, Tuomilehto J, Umpierrez GE. Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. BMJ Open Diabetes Res Care. 2020 May;8(1):e001248.
http://pubmed.ncbi.nlm.nih.gov/32366501/

Learning Outcomes

By the end of this module, you will be able to:

✓ Summarise how the principles of the ADA/EASD consensus guidelines should be applied to the management of diabetes during Ramadan according to the 2020 recommendations for management of diabetes during Ramadan update

✓ Interpret recent clinical trials and real-world evidence for the use of SGLT-2 inhibitors and GLP-1 receptor agonists by people with type 2 diabetes wishing to fast during Ramadan

✓ Develop management plans for patients with type 2 diabetes who wish to fast during Ramadan


This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.


Contributors

Dr
Ehtasham Ahmad
Author, Assessment Setter
Professor
Nancy Elbarbary
Expert Reviewer